C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/12 (2006.01) A61K 31/47 (2006.01) A61K 31/675 (2006.01) A61K 31/695 (2006.01) C07D 217/26 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01) C07D 413/14 (2006.01) C07D 417/12 (2006.01) C07D 417/14 (2006.01) C07F 7/10 (2006.01) C07F 9/6558 (2006.01)
Patent
CA 2259431
This invention provides 1,2,3,4-tetrahydroisoquinoline compounds and their pharmaceutically-acceptable salts, pharmaceutical formulations of said compounds, and methods for treating hyperglycemia associated with non-insulin dependent diabetes and for treating hyperlipidemia.
L'invention concerne des composés 1,2,3,4-tétrahydro-isoquinoline et leurs sels pharmaceutiquement acceptables, ainsi que des préparations pharmaceutiques desdits composés et des procédés de traitement de l'hypoglycémie associée aux diabètes non insulinodépendants et de l'hyperlipidémie.
Dominianni Samuel James
Gritton William Harlan
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Hypoglycemic and hypolipidemic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoglycemic and hypolipidemic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycemic and hypolipidemic compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1838184